secwatch.observer — SEC 8-K summary
======================================

Issuer:     MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI)
CIK:        0001823239
Form:       8-K
Filed at:   2025-11-06T23:59:59+00:00
Accession:  0001823239-25-000117
Event type: earnings
Sentiment:  negative
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Maravai Q3 revenue $41.6M, net loss $45.1M, Adj EBITDA -$10.8M
--------------------------------------------------------------

- Revenue of $41.6 million, net loss of $45.1 million, and Adjusted EBITDA loss of $10.8 million for Q3 2025.
- Full-year 2025 revenue guidance of approximately $185 million, excluding potential high-volume CleanCap orders.
- CEO expects double-digit sequential revenue growth in Q4 2025, citing strong funnel and order velocity at TriLink.
- Organizational restructuring and operating cost reduction initiatives remain on track.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1823239/000182323925000117/0001823239-25-000117-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1823239/000182323925000117/mrvi-20251106.htm
  HTML page:      https://secwatch.observer/filing/0001823239-25-000117

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer